FDA panel recommends allowing birth control pill to be sold over the counter
USA Today covers an FDA advisory panel’s unanimous recommendation for the agency to approve Opill, a daily progestin-only birth control pill, for over the counter use.
USA Today covers an FDA advisory panel’s unanimous recommendation for the agency to approve Opill, a daily progestin-only birth control pill, for over the counter use.